PATENT CLAIM ANALYSIS

Application Number: 16091257
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["424", "204100"]

Abstract:
Novel nucleic acid molecules encoding a pre-fusion RSV F protein or immunologically active part thereof are described, and the pre-fusion RSV F protein contains the amino acid sequence of SEQ ID NO: 1 or 2. Use of the nucleic acid molecules, or vectors containing the nucleic acid molecules, as a vaccine against respiratory syncytial virus (RSV) is also described.

Claim (Index 17):
An isolated recombinant nucleic acid that forms the genome of a recombinant human adenovirus that comprises a nucleic acid encoding a pre-fusion RSV F protein or fragment thereof, wherein the pre-fusion RSV F protein comprises the amino acid sequence of SEQ ID NO:  1  or  2 .

Metadata:
- Claim Count in Document: 35.0
- Percentile: 97.0
- Lexical Diversity: 1.52273
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13849380', '13849393', '15601278', '15701872', '14932789']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7906206121756035
- 35 USC 102 Novelty (BERT): 0.55731185605454
- Combined Prediction Score: 0.7672897365634972
- Mean Citation Score: 397.23644
- Max Citation Score: 435.11392
- Similarity Product: 358.89094096782685

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test